Kiromic Biopharma Inc. (KRBP): Price and Financial Metrics


Kiromic Biopharma Inc. (KRBP): $0.35

0.02 (+7.55%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add KRBP to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

KRBP Stock Price Chart Interactive Chart >

Price chart for KRBP

KRBP Price/Volume Stats

Current price $0.35 52-week high $11.00
Prev. close $0.33 52-week low $0.23
Day low $0.35 Volume 95,300
Day high $0.37 Avg. volume 261,353
50-day MA $0.64 Dividend yield N/A
200-day MA $1.71 Market Cap 5.53M

Kiromic Biopharma Inc. (KRBP) Company Bio


Kiromic Biopharma, Inc. operates as a biotechnology company, which engages in the development of cancer engineered immunotherapies. Its technologies include Intelligent Immunotherapy, Diamond AI, CancerSplice, ABBIE, and CAR-T Proprietary Binder Technology. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX.


KRBP Latest News Stream


Event/Time News Detail
Loading, please wait...

KRBP Latest Social Stream


Loading social stream, please wait...

View Full KRBP Social Stream

Latest KRBP News From Around the Web

Below are the latest news stories about Kiromic Biopharma Inc that investors may wish to consider to help them evaluate KRBP as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Rise and shine!

William White on InvestorPlace | March 9, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Welcome back, trader!

William White on InvestorPlace | March 7, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning!

William White on InvestorPlace | March 3, 2022

Kiromic BioPharma Announces Changes in Management, Board of Directors

HOUSTON, February 03, 2022--Kiromic BioPharma Announces Changes in Management, Board of Directors

Yahoo | February 3, 2022

Kiromic BioPharma Appoints Frank Tirelli and Dr. Karen Reeves to Company’s Board of Directors

HOUSTON, February 03, 2022--Kiromic BioPharma Appoints Frank Tirelli and Dr. Karen Reeves to Company’s Board of Directors

Yahoo | February 3, 2022

Read More 'KRBP' Stories Here

KRBP Price Returns

1-mo -41.47%
3-mo -42.74%
6-mo -87.72%
1-year -95.73%
3-year N/A
5-year N/A
YTD -77.12%
2021 -81.94%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.1088 seconds.